Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice

Molecular and Cellular Biology

Volumn 24, Issue 12, 2004, Pages 5304-5313

  Pendás, Alberto M ^a,e   Folgueras, Alicia R ^a   Llano, Elena ^a,f   Caterina, John ^c   Frerard, Françoise ^d   Rodríguez, Francisco ^a   Astudillo, Aurora ^b   Noël, Agnès ^d   Birkedal Hansen, Henning ^c   López Otín, Carlos ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e UNIVERSIDAD DE OVIEDO   (Spain)

^f Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 19; UNCLASSIFIED DRUG;

ADIPOCYTE; ANGIOGENESIS; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVITY; ENZYME DEFICIENCY; FERTILITY; HYPERTROPHY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; OVULATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SKIN CANCER; TUMOR GROWTH;

ADIPOCYTES; ANIMALS; BASE SEQUENCE; CARCINOGENS; CELL SIZE; DIET; DNA, COMPLEMENTARY; FEMALE; GENE TARGETING; HUMANS; MALE; METALLOENDOPEPTIDASES; METHYLCHOLANTHRENE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; OBESITY; PHENOTYPE; SKIN NEOPLASMS;

EID: 2942629103     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.12.5304-5313.2004     Document Type: Article

References (41)

1. Alexander, C. M., S. Selvarajan, J. Mudgett, and Z. Werb. 2001. Stromelysin-1 regulates adipogenesis during mammary gland involution. J. Cell Biol. 152:693-703.
2. Balbin, M., A. Fueyo, A. M. Tester, A. M. Pendas, A. S. Pitiot, A. Astudillo, C. M. Overall, S. D. Shapiro, and C. Lopez-Otin. 2003. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat. Genet. 35:252-257.
3. Blacher, S., L. Devy, M. F. Burbridge, G. Roland, G. Tucker, A. Noel, and J. M. Foidart. 2001. Improved quantification of angiogenesis in the rat aortic ring assay. Angiogenesis 4:133-142.
4. Bouloumie, A., C. Sengenes, G. Portolan, J. Galitzky, and M. Lafontan. 2001. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 50:2080-2086.
5. Brinckerhoff, C. E., and L. M. Matrisian. 2002. Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell. Biol. 3:207-214.
6. Chavey, C., B. Mari, M. N. Monthouel, S. Bonnafous, P. Anglard, E. Van Obberghen, and S. Tartare-Deckert. 2003. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J. Biol. Chem. 278:11888-11896.
7. Cossins, J., T. J. Dudgeon, G. Catlin, A. J. Gearing, and J. M. Clements. 1996. Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem. Biophys. Res. Commun. 228:494-498.
8. Coussens, L. M., B. Fingleton, and L. M. Matrisian. 2002. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295:2387-2392.
9. Croissandeau, G., M. Chretien, and M. Mbikay. 2002. Involvement of matrix metalloproteinases in the adipose conversion of 3T3-L1 preadipocytes. Biochem. J. 364:739-746.
10. Devy, L., S. Blacher, C. Grignet-Debrus, K. Bajou, V. Masson, R. D. Gerard, A. Gils, G. Carmeliet, P. Carmeliet, P. J. Declerck, A. Noel, and J. M. Foidart. 2002. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J. 16:147-154.
11. Egeblad, M., and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2:161-174.
12. Freije, J. M., M. Balbin, A. M. Pendas, L. M. Sanchez, X. S. Puente, and C. Lopez-Otin. 2003. Matrix metalloproteinases and tumor progression. Adv. Exp. Med. Biol. 532:91-107.
13. Halpert, I., U. I. Sires, J. D. Roby, S. Potter-Perigo, T. N. Wight, S. D. Shapiro, H. G. Welgus, S. A. Wickline, and W. C. Parks. 1996. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc. Natl. Acad. Sci. USA 93:9748-9753.
14. Hieta, N., U. Impola, C. Lopez-Otin, U. Saarialho-Kere, and V. M. Kahari. 2003. Matrix metalloproteinase-19 expression in dermal wounds and by fibroblasts in culture. J. Investig. Dermatol. 121:997-1004.
15. Jackson, R. S., J. W. Creemers, S. Ohagi, M. L. Raffin-Sanson, L. Sanders, C. T. Montague, J. C. Hutton, and S. O'Rahilly. 1997. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 16:303-306.
16. Kawaguchi, N., X. Xu, R. Tajima, P. Kronqvist, C. Sundberg, F. Loechel, R. Albrechtsen, and U. M. Wewer. 2002. ADAM 12 protease induces adipogenesis in transgenic mice. Am. J. Pathol. 160:1895-1903.
17. Kim, C. S., T. Kawada, H. Yoo, B. S. Kwon, and R. Yu. 2003. Macrophage inflammatory protein-related protein-2, a novel CC chemokine, can regulate preadipocyte migration and adipocyte differentiation. FEBS Lett. 548:125-130.
18. Kolb, C., S. Mauch, U. Krawinkel, and R. Sedlacek. 1999. Matrix metalloproteinase-19 in capillary endothelial cells: expression in acutely, but not in chronically, inflamed synovium. Exp. Cell Res. 250:122-130.
19. Konttinen, Y. T., M. Ainola, H. Valleala, J. Ma, H. Ida, J. Mandelin, R. W. Kinne, S. Santavirta, T. Sorsa, C. Lopez-Otin, and M. Takagi. 1999. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann. Rheum Dis. 58:691-697.
20. Kurisaki, T., A. Masuda, K. Sudo, J. Sakagami, S. Higashiyama, Y. Matsuda, A. Nagabukuro, A. Tsuji, Y. Nabeshima, M. Asano, Y. Iwakura, and A. Sehara-Fujisawa. 2003. Phenotypic analysis of Meltrin alpha (ADAM12)-deficient mice: involvement of Meltrin alpha in adipogenesis and myogenesis. Mol. Cell. Biol. 23:55-61.
21. Lijnen, H. R., E. Maquoi, L. B. Hansen, B. Van Hoef, L. Frederix, and D. Collen. 2002. Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler. Thromb. Vasc. Biol. 22:374-379.
22. Lijnen, H. R., H. B. Van, L. Frederix, M. C. Rio, and D. Collen. 2002. Adipocyte hypertrophy in stromelysin-3 deficient mice with nutritionally induced obesity. Thromb. Haemost. 87:530-535.
23. MacDougald, O. A., and S. Mandrup. 2002. Adipogenesis: forces that tip the scales. Trends Endocrinol. Metab. 13:5-11.
24. Maquoi, E., D. Demeulemeester, G. Voros, D. Collen, and H. R. Lijnen. 2003. Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation. Thromb. Haemost. 89:696-704.
25. Maquoi, E., C. Munaut, A. Colige, D. Collen, and H. R. Lijnen. 2002. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 51:1093-1101.
26. Masson, V. V., L. Devy, C. Grignet-Debrus, S. Bernt, K. Bajou, S. Blacher, G. Roland, Y. Chang, T. Fong, P. Carmeliet, J. M. Foidart, and A. Noel. 2002. Mouse aortic ring assay: a new approach of the molecular genetics of angiogenesis. Biol. Proced. Online 4:24-31.
27. Mueller, M. S., S. Mauch, and R. Sedlacek. 2000. Structure of the human MMP-19 gene. Gene 252:27-37.
28. Nagase, H., and J. F. Woessner, Jr. 1999. Matrix metalloproteinases. J. Biol. Chem. 274:21491-21494.
29. Naggert, J. K., L. D. Fricker, O. Varlamov, P. M. Nishina, Y. Rouille, D. F. Steiner, R. J. Carroll, B. J. Paigen, and E. H. Leiter. 1995. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat. Genet. 10:135-142.
30. Overall, C. M., and C. Lopez-Otin. 2002. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer. 2:657-672.
31. Pendas, A. M., M. Balbin, E. Llano, M. G. Jimenez, and C. Lopez-Otin. 1997. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13). Genomics 40:222-233.
32. Pendas, A. M., V. Knauper, X. S. Puente, E. Llano, M. G. Mattei, S. Apte, G. Murphy, and C. Lopez-Otin. 1997. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J. Biol. Chem. 272:4281-4286.
33. Rangwala, S. M., and M. A. Lazar. 2000. Transcriptional control of adipogenesis. Annu. Rev. Nutr. 20:535-559.
34. Sadowski, T., S. Dietrich, F. Koschinsky, and R. Sedlacek. 2003. Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferatin, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3. Mol. Biol. Cell 14:45694580.
35. Sadowski, T., S. Dietrich, M. Muller, B. Havlickova, M. Schunck, E. Proksch, M. S. Muller, and R. Sedlacek. 2003. Matrix metalloproteinase-19 expression in normal and diseased skin: dysregulation by epidermal proliferation. J. Investig. Dermatol. 121:989-996.
36. Sedlacek, R., S. Mauch, B. Kolb, C. Schatzlein, H. Eibel, H. H. Peter, J. Schmitt, and U. Krawinkel. 1998. Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis. Immunobiology 198:408-423.
37. Selvarajan, S., L. R. Lund, T. Takeuchi, C. S. Craik, and Z. Werb. 2001. A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat. Cell Biol. 3:267-275.
38. Stracke, J. O., A. J. Fosang, K. Last, F. A. Mercuri, A. M. Pendas, E. Llano, R. Perris, P. E. Di Cesare, G. Murphy, and V. Knauper. 2000. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP). FEBS Lett. 478:52-56.
39. Stracke, J. O., M. Hutton, M. Stewart, A. M. Pendas, B. Smith, C. Lopez-Otin, G. Murphy, and V. Knauper. 2000. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19: evidence for a role as a potent basement membrane degrading enzyme. J. Biol. Chem. 275:14809-14816.
40. Vu, T. H., and Z. Werb. 2000. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14:2123-2133.
41. Yang, M., and M. Kurkinen. 1998. Cloning and characterization of a novel matrix metalloproteinase (MMP), CMMP, from chicken embryo fibroblasts. CMMP, Xenopus XMMP, and human MMP19 have a conserved unique cysteine in the catalytic domain. J. Biol. Chem. 273:17893-17900.